Braveheart Bio, Inc
Price
FilingsNewest: 10-Q, Quarterly reportSep 8 →Insiders18 insiders bought $159.0M in 13 open-market buys. No sales.→Financing →
From the filings
Figures
- Cash and equivalents
- $122.8Mat the last balance sheet
- Shares outstanding
- 7.5M shareson issue